Neeraj Agarwal, MD, professor of medicine at the University of Utah and one of the world authorities on prostate cancer and GU oncology visits with me on the podcast. He discusses management decisions for patients with advanced or metastatic prostate cancer, including weariness in using ADT for many patients with co-morbidities and how clinicians are currently weighing existing regimens.
No one knows prostate cancer more than Neeraj; I always learn from him and I am one of his biggest fans.
Dr Nabhan and the podcast guests have no relevant financial disclosures.
This podcast is produced by the Journal of Clinical Pathways.
Dr. Joe Mikhael, Chief Medical Officer of the International Myeloma Foundation (IMF) and Professor at TGen, takes us beyond his medical career to explore the personal experiences that have shaped his journey in oncology. Dr. Mikhael discusses the IMF’s targeted strategies for reducing health disparities among diverse ethnic and racial groups affected by myeloma, shedding
Tom Beer, Chief Medical Officer of the Multi-Cancer Early Detection (MCED) program at Exact Sciences, delves into the groundbreaking science behind MCED tests, which use advanced biomarkers for early detection of multiple cancer types. On this Healthcare Unfiltered episode, he explains who may be eligible for these tests, how to interpret results to avoid unnecessary
In this special episode, I give up the microphone to guest host Kelly Ryerson, who takes over the show asking questions about my new book “The Cancer Journey.”
